07/14/2026 | Companies

Americans for Safe and Effective Medicines, ASEM, clinical testing, compounded GLP-1, consumer awareness, consumer survey, counterfeit medicines, drug compounding, drug safety, drug shortages, FDA, FDA approval, FDA inspections, GLP-1 medications, GLP-1 therapy, healthcare advocacy, healthcare policy, healthcare regulation, healthcare transparency, illegal compounding, ingredient sourcing, injectable medications, mass compounding, medical spas, medication safety, misleading marketing, online pharmacies, patient education, patient safety, pharmaceutical industry, pharmaceutical regulation, prescription drugs, primary care physicians, product recalls, public health, quality standards, regulatory compliance, state enforcement, sterility concerns, telehealth, warning letters